Analyst Ratings

Upgrades, downgrades, and price-target changes from Wall Street firms.

Analyst Ratings

Noble Capital Markets Reiterates Buy Rating on Lands' End

Noble Capital Markets maintains its buy rating on Lands' End with a $20 price target.

$LE
Analyst Ratings

Northland Capital Markets Reiterates Buy Rating on Sezzle Inc.

Northland Capital Markets maintains its buy rating on Sezzle Inc. with a $160 price target.

$SEZL
Analyst Ratings

Raymond James Reiterates Buy Rating on MNR

Raymond James maintains its buy rating on MNR, setting a price target of $18.

$MNR
Analyst Ratings

Raymond James Reaffirms Buy Rating on Crescent Energy

Raymond James maintains its buy rating on Crescent Energy, setting an $18 price target.

$CRGY
Analyst Ratings

B. Riley Securities Reiterates Buy Rating on ICHR

B. Riley Securities maintains its buy rating on ICHR with a $125 price target.

$ICHR
Analyst Ratings

B. Riley Securities Reiterates Buy Rating on CLPT with $30 Target

B. Riley Securities maintains its buy rating on CLPT, setting a price target of $30.

$CLPT
Analyst Ratings

Roth Capital Reiterates Buy Rating on ACM Research

Roth Capital maintains a buy rating for ACM Research, Inc. with a $125 price target.

$ACMR
Analyst Ratings

Evercore ISI Reiterates Buy Rating for Accenture plc

Evercore ISI Group maintains its buy rating on Accenture plc with a $180 price target.

$ACN
Analyst Ratings

Rosenblatt Reiterates Buy Rating on Twilio Inc.

Rosenblatt maintains a buy rating on Twilio with a $230 price target.

$TWLO
Analyst Ratings

HC Wainwright Reiterates Buy Rating on NVCR

HC Wainwright maintains its optimistic stance on NVCR, setting a $46 price target.

$NVCR
Analyst Ratings

Canaccord Genuity Reiterates Buy Rating for Better Home & Finance

Analyst Joseph Vafi at Canaccord Genuity maintains a buy rating with a $42 price target.

$BETR
Analyst Ratings

Chardan Capital Reiterates Buy Rating on Opus Genetics

Chardan Capital has reiterated its buy rating for Opus Genetics with a $13 price target.

$IRD
Analyst Ratings

Goldman Sachs Reiterates Buy Rating on Jabil Inc.

Goldman Sachs maintains its buy rating on Jabil Inc. with a $482 price target.

$JBL
Analyst Ratings

Oppenheimer Reaffirms Buy Rating on Darden Restaurants

Oppenheimer maintains its buy rating for Darden Restaurants with a $235 target.

$DRI
Analyst Ratings

Oppenheimer Reiterates Buy Rating on Hamilton Lane

Oppenheimer maintains its buy rating on Hamilton Lane with a $176 price target.

$HLNE
Analyst Ratings

Scotiabank Reiterates Buy Rating for TRNO

Scotiabank maintains its buy rating on TRNO, setting a $68 price target.

$TRNO
Analyst Ratings

Scotiabank Reiterates Buy Rating on Welltower Inc.

Scotiabank maintains its buy rating on Welltower Inc., setting a price target of $232.

$WELL
Analyst Ratings

Piper Sandler Reiterates Buy Rating on Tyson Foods

Piper Sandler maintains a buy rating on Tyson Foods with a $78 price target.

$TSN
Analyst Ratings

UBS Reiterates Buy Rating on Corporación Inmobiliaria Vesta

UBS maintains its buy rating for Vesta with a $43 target.

$VTMX
Analyst Ratings

Evercore ISI Reiterates Buy Rating on Travere Therapeutics

Evercore ISI maintains a buy rating on Travere Therapeutics with a $60 price target.

$TVTX
Analyst Ratings

Barclays Reiterates Buy Rating on Duke Energy

Barclays analyst Nicholas Campanella maintains a 'buy' rating with a $134 price target for Duke Energy.

$DUK
Analyst Ratings

Barclays Reiterates Buy Rating on Hims & Hers Health

Barclays maintains its Buy rating with a $39 target for Hims & Hers Health.

$HIMS
Analyst Ratings

Barclays Reaffirms Buy Rating for Jabil Inc. with $426 Target

Jabil Inc. receives a reaffirmed buy rating from Barclays, with a price target of $426.

$JBL
Analyst Ratings

Rosenblatt Reiterates Buy Rating for Micron Technology, Sets $1200 Target

Rosenblatt maintains its buy rating on Micron Technology with a price target of $1200.

$MU